Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| RARE | CLUSTER | neutral | 2/10 | Two insiders at Ultragenyx sold a combined $97K in open-market transactions on June 15, 2026. The EVP/Chief Legal Office | Jun 15, 2026 |
| ORKA | CLUSTER | neutral | 2/10 | Two insiders at Oruka Therapeutics, General Counsel Paul Quinlan and Director Carl Dambkowski, sold a combined $933K in | Jun 15, 2026 |
| ANIP | CLUSTER | neutral | 2/10 | Three ANIP insiders (Director, CFO, and General Counsel) sold a total of $468K in open-market transactions over a 7-day | Jun 15, 2026 |
| LYEL | CLUSTER | neutral | 2/10 | Lyell Immunopharma insiders executed negligible open-market sales totaling $8K (0.003% of market cap) in early May 2026, | Jun 15, 2026 |
| NATR | CLUSTER | neutral | 2/10 | Two EVP/Presidents at Nature's Sunshine Products sold a combined $262K in open-market transactions over a 7-day window. | Jun 15, 2026 |
| ONC | CLUSTER | neutral | 2/10 | Five BeOne Medicines insiders, including the CEO, sold a total of $1.98M in open-market shares over a one-week window. T | Jun 15, 2026 |
| ONC | CLUSTER | neutral | 2/10 | Five insiders at BeOne Medicines (ONC) sold a total of $2.0M in shares on June 8, 2026, led by CEO John Oyler ($1.03M). | Jun 15, 2026 |
| CYTK | CLUSTER | neutral | 2/10 | Two CYTK insiders, including the CEO and EVP of R&D, sold a combined $766K in open-market transactions over a week. The | Jun 15, 2026 |
| ONC | CLUSTER | neutral | 2/10 | Five BeOne Medicines insiders, including the CEO, sold a total of $2.0M in shares on June 8, 2026. This represents only | Jun 15, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | UTHR CEO and CFO sold shares totaling $239K in open-market transactions over a two-day window, alongside routine option | Jun 15, 2026 |
| TNXP | CLUSTER | neutral | 3/10 | Three insiders including CEO Seth Lederman made small open-market purchases totaling $132K, representing ~0.07% of TNXP' | Jun 15, 2026 |
| PCRX | CLUSTER | neutral | 3/10 | Pacira BioSciences saw two insider sales totaling $372K over a week, including the Chief Administrative Officer and SVP | Jun 12, 2026 |
| SPRY | CLUSTER | neutral | 3/10 | Two C-suite insiders at ARS Pharmaceuticals (SPRY) sold shares on June 12, 2026, totaling $284K in open-market sales. Th | Jun 12, 2026 |
| CYRX | CLUSTER | neutral | 4/10 | Two CYRX insiders (CFO and a Director) sold a combined ~$3.12M in open-market shares over a 7-day window, representing ~ | Jun 12, 2026 |
| QURE | CLUSTER | neutral | 3/10 | Two directors sold a combined ~$148K in QURE stock over the past week, with the larger June 11 cluster showing 6 directo | Jun 12, 2026 |
| QURE | CLUSTER | neutral | 3/10 | Six uniQure insiders (five directors and the chief customer & strategy officer) sold a total of $701K in open-market sal | Jun 12, 2026 |
| QURE | CLUSTER | neutral | 2/10 | Four uniQure directors sold a total of 7,972 shares for approximately $215,722 on June 11, 2026, all at $27.06 per share | Jun 12, 2026 |
| QURE | CLUSTER | neutral | 2/10 | Three uniQure directors each sold ~$54K of stock on June 11, 2026, totaling ~$162K, a trivial 0.01% of the $1.7B market | Jun 12, 2026 |
| LGND | CLUSTER | neutral | 2/10 | Two directors at Ligand Pharmaceuticals sold a combined ~$1.31M in shares over two days, representing 0.026% of the comp | Jun 12, 2026 |
| IPSC | CLUSTER | neutral | 2/10 | Two insiders at Century Therapeutics (IPSC) sold a combined ~$1,632 in open-market sales on June 8, 2026, while five dir | Jun 12, 2026 |
| INDV | CLUSTER | neutral | 4/10 | Two senior insiders at Indivior (CFO and CSO) sold a combined $2.06M in open-market sales over a 4-day window. While the | Jun 12, 2026 |
| ADTX | CLUSTER | bearish | 6/10 | Aditxt insiders, HRT Financial LP (10% owner) and 10% owner Sandie Gong, sold a combined ~2.93M shares for ~$47K in a si | Jun 12, 2026 |
| SMMT | CLUSTER | bullish | 6/10 | Both co-CEOs of Summit Therapeutics (SMMT) each purchased 3.81M shares open-market on June 12, 2026, at $13.12, aggregat | Jun 12, 2026 |
| AXSM | CLUSTER | neutral | 4/10 | A cluster of insider sales at Axsome Therapeutics (AXSM) over the past week totaled ~$20.2M in open-market transactions, | Jun 11, 2026 |
| HOWL | CLUSTER | bearish | 5/10 | Two insiders at Werewolf Therapeutics, a director and a 10% owner, sold a total of ~$156K in open-market sales over two | Jun 11, 2026 |
| NATR | CLUSTER | neutral | 4/10 | Two regional EVP Presidents at Nature's Sunshine sold shares totaling $439K (0.12% of market cap) in open-market transac | Jun 11, 2026 |
| NUVL | CLUSTER | neutral | 2/10 | Two Nuvalent insiders (CEO and Chief Development Officer) sold a combined ~$3.56M in open-market shares on June 8-9, 202 | Jun 11, 2026 |
| MGX | CLUSTER | neutral | 2/10 | Three insiders at Metagenomi, including the CFO, sold a total of ~$9K in open-market sales on June 5, 2026, at ~$1.30/sh | Jun 11, 2026 |
| MGX | CLUSTER | neutral | 2/10 | Three insiders at Metagenomi Therapeutics, including the CFO, sold a total of $9K in open-market sales on June 5, 2026, | Jun 11, 2026 |
| MGX | CLUSTER | neutral | 2/10 | Three insiders at Metagenomi Therapeutics, including the CFO, sold a total of ~$9K in open-market sales on June 5, 2026. | Jun 11, 2026 |